Additionally, in concert with our animal experiments, it was reported, clinically, that autoantibodies against the β1-AR existing in the sera of DCM patients also present a time-course decrease and cardiac autoantibodies in patients with DCM become undetectable with disease progression [24]–[25]. The gene discussed is ADRB1; the disease is familial dilated cardiomyopathy.